Algeria vs Cuba: Cases started on MDR-TB treatment

Algeria
9
in 2023
Cuba
9
in 2024
Algeria rank
123rd
Cuba rank
123rd

Cases started on MDR-TB treatment over time

  • Algeria
  • Cuba
020406080100200820162024

How they compare

Algeria currently reports 9 against 9 in Cuba, a difference of 0.

The two have swapped places 1 time across 9 shared years of data; in 2010 it was Algeria ahead.

Algeria ranks 123rd and Cuba ranks 123rd of 191 countries.

Algeria has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Algeria Cuba Difference Ahead
2010s 64.5 10.17 54.33 Algeria
2020s 21 10.67 10.33 Algeria

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cases started on mdr-tb treatment, Algeria or Cuba?
Algeria, at 9 against 9 in Cuba as of 2023.
What is the difference in cases started on mdr-tb treatment between Algeria and Cuba?
0, with Algeria ahead.
How many years of comparable data are there for Algeria and Cuba?
9 years are reported by both, from 2010 to 2023.
How do Algeria and Cuba rank globally for cases started on mdr-tb treatment?
Algeria ranks 123rd and Cuba ranks 123rd of 191 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Algeria vs Cuba: Cases started on MDR-TB treatment. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 August 2026, from https://health.statizoid.com/compare/cases-started-on-mdr-tb-treatment/algeria/cuba/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/cases-started-on-mdr-tb-treatment/algeria/cuba/">Algeria vs Cuba: Cases started on MDR-TB treatment</a> — Statizoid

About this data

Indicator
Cases started on MDR-TB treatment
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,209 data points, 2005–2024
Last refreshed